T细胞子集特征和分布在结肠直肠癌前癌症-癌症谱中演变
Yasutoshi Takashima1, Andressa Dias Costa1, Naohiko Akimoto2,3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer immunology research
|November 12, 2025
概括
在结直肠癌前体和侵袭性瘤中,T细胞透不同. 状病变显示出更多的内皮T细胞,而前体通常具有比癌症更高的T细胞密度.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 免疫微环境是结肠直肠癌 (CRC) 的关键,但对前体癌症了解甚少.
- 透的T细胞在结直肠瘤谱中可能有所不同.
研究的目的:
- 研究T细胞透模式在结直肠癌前体和入侵性结直肠癌的研究.
- 了解CRC发育过程中的免疫微环境演变.
主要方法:
- 通过多谱免疫光检测T细胞标记物 (CD3,CD4,CD8,FOXP3,CD45RA,CD45RO) 分析了1825个组织样本 (前体和癌瘤).
- 应用监督机器学习来量化T细胞表型 (天真,记忆,调控).
主要成果:
- 前体通常比侵入性CRC具有更高的CD3+CD4+和CD3+CD8+细胞密度.
- 状病变 (超塑性息肉,状状病变) 显示皮内CD3+CD8+细胞增加.
- 腺瘤中较大的小性成分与较少的内皮细胞CD3+CD8+细胞相关.
结论:
- 在整个结直肠瘤谱中,T细胞透模式显著变化.
- 在CRC的前体进展过程中,免疫微环境的组成发生变化.
相关概念视频
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Renewal of Intestinal Stem Cells
3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K


